meu6 Antibody

What is the meu6 antibody and what organism does it target?

The meu6 antibody is a polyclonal antibody raised in rabbits against the recombinant meu6 protein from Schizosaccharomyces pombe (fission yeast), specifically strain 972 / ATCC 24843 . The antibody targets the protein encoded by the meu6 gene (UniProt accession number O94356) and is designed for detecting this protein in various experimental contexts . The meu6 protein in S. pombe is primarily studied in the context of meiotic processes, as its name (meiotic upregulated gene 6) suggests.

What are the validated applications for the meu6 antibody?

The meu6 antibody has been validated for two primary applications: Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) . These applications allow researchers to:

• Detect and quantify meu6 protein levels in cell lysates or purified samples via ELISA

• Analyze meu6 protein expression, molecular weight, and potential post-translational modifications via Western Blot

• Identify protein-protein interactions involving meu6 through co-immunoprecipitation followed by Western Blot

Researchers should validate the antibody for other applications such as immunofluorescence or chromatin immunoprecipitation before proceeding with critical experiments.

What is the recommended storage protocol for maintaining meu6 antibody efficacy?

For optimal performance, the meu6 antibody should be stored at -20°C or -80°C immediately upon receipt . The manufacturer specifically advises against repeated freeze-thaw cycles, as these can degrade the antibody and reduce its activity . The formulation includes 50% glycerol and 0.01M PBS (pH 7.4) with 0.03% Proclin 300 as a preservative, which helps maintain stability during storage . For long-term projects, it is recommended to aliquot the antibody into smaller volumes before freezing to minimize freeze-thaw cycles.

How should dilution factors be optimized for Western Blot applications with meu6 antibody?

When optimizing dilution factors for Western Blot applications with the meu6 antibody, researchers should follow a systematic approach:

• Begin with a standard dilution range test (1:500, 1:1000, 1:2000, 1:5000)

• Load equal amounts of protein from S. pombe lysates (15-30 μg per lane)

• Assess signal-to-noise ratio and band specificity at each dilution

• Consider cross-reactivity controls using knockout strains if available

Results from optimization experiments should be documented in a table format similar to this:

The optimal dilution will vary based on protein expression levels, detection methods, and exposure times, requiring customization for each experimental system.

What controls should be included when working with meu6 antibody in S. pombe studies?

A comprehensive experimental design with meu6 antibody should include the following controls:

• Positive control: Wild-type S. pombe cells during meiosis when meu6 expression is upregulated

• Negative control: Either:

  • meu6 deletion mutant (Δmeu6) strain

  • Pre-immune serum at the same concentration as the antibody

  • Secondary antibody only

• Loading control: Detection of a constitutively expressed protein (e.g., actin, tubulin) to normalize protein levels

• Competitive peptide control: Pre-incubation of the antibody with excess meu6 recombinant protein to confirm specificity

These controls help validate antibody specificity and ensure experimental reliability, particularly when investigating meu6 expression patterns during different cell cycle phases or meiotic stages.

How should researchers approach epitope mapping for the meu6 antibody?

Epitope mapping for the meu6 antibody involves several strategic approaches:

• Computational prediction: Use algorithms to predict antigenic determinants on the meu6 protein sequence

• Peptide array analysis: Test binding to overlapping synthetic peptides spanning the meu6 sequence

• Recombinant fragment analysis: Generate truncated versions of meu6 protein to localize the binding region

• Mutational analysis: Introduce point mutations to identify critical binding residues

As a polyclonal antibody generated against the full recombinant meu6 protein, multiple epitopes are likely recognized . Mapping these epitopes is particularly important when comparing results across different experimental conditions or when developing new detection methodologies.

How can the meu6 antibody be used to study protein expression during meiosis in S. pombe?

The meu6 antibody provides a valuable tool for examining protein expression dynamics during meiosis in S. pombe:

• Time-course analysis: Collect samples at defined intervals following meiotic induction

• Subcellular localization: Combine with cellular fractionation to track meu6 localization changes

• Co-immunoprecipitation: Identify meiosis-specific protein interaction partners

• Chromatin association: Examine potential DNA-binding activity during specific meiotic phases

A typical experimental workflow might include:

• Synchronize S. pombe cells and induce meiosis

• Harvest cells at 0, 2, 4, 6, 8, and 10 hours post-induction

• Prepare protein extracts and perform Western blot analysis with the meu6 antibody

• Quantify band intensities normalized to a loading control

• Plot expression profile across the meiotic time course

This approach can reveal the temporal expression pattern of meu6 and provide insights into its regulation and function during meiosis.

What methodologies enable quantitative analysis of meu6 protein levels using this antibody?

Quantitative analysis of meu6 protein levels can be achieved through several methodologies:

• Quantitative Western Blotting:

  • Use internal loading controls

  • Include calibration standards with known quantities of recombinant meu6

  • Employ digital imaging systems with linear dynamic range

  • Apply densitometry software for quantification

• Quantitative ELISA:

  • Develop a standard curve using purified recombinant meu6 protein

  • Optimize antibody concentration and incubation conditions

  • Employ appropriate statistical analysis of replicates

• Multiplexed protein analysis:

  • Adapt the antibody for use in multiplexed assays to measure meu6 alongside other proteins

  • Validate cross-reactivity and potential interference

A comparative analysis of these methods reveals:

Selection of the appropriate method depends on specific research questions, sample availability, and required precision.

What approaches can resolve conflicting results from meu6 antibody experiments?

When encountering conflicting results using the meu6 antibody, researchers should implement a systematic troubleshooting approach:

• Antibody validation:

  • Reconfirm antibody specificity using knockout controls

  • Verify antibody performance with fresh aliquots

  • Consider lot-to-lot variations that might affect performance

• Experimental conditions assessment:

  • Review buffer compositions and pH conditions

  • Evaluate protein extraction methods for potential selective loss

  • Assess protein modifications that might mask or alter epitopes

• Methodological triangulation:

  • Compare results across multiple detection techniques

  • Use orthogonal approaches (e.g., mass spectrometry) for verification

  • Implement alternative antibodies targeting different epitopes if available

• Biological context considerations:

  • Examine cell cycle stage variations in protein expression

  • Assess environmental or experimental stressors that might alter expression

  • Consider strain-specific differences in protein sequence or expression

Documenting all experimental variables systematically helps identify sources of variability and facilitates resolution of conflicting results.

What strategies minimize non-specific binding when using meu6 antibody in complex samples?

Minimizing non-specific binding requires optimization of several parameters:

• Blocking optimization:

  • Test different blocking agents (BSA, non-fat milk, casein, commercial blockers)

  • Determine optimal blocking time and temperature

  • Consider dual blocking strategies for challenging samples

• Antibody dilution and incubation:

  • Optimize antibody concentration through titration experiments

  • Evaluate incubation temperature effects (4°C, room temperature)

  • Test extended incubation times with more dilute antibody solutions

• Wash protocol refinement:

  • Increase wash buffer stringency (salt concentration, detergent type)

  • Extend washing duration and frequency between steps

  • Consider temperature variations during wash steps

• Sample preparation improvements:

  • Pre-clear lysates with protein A/G beads before antibody addition

  • Implement additional purification steps for complex samples

  • Use detergent optimization to reduce hydrophobic interactions

Each strategy should be systematically tested and documented to establish optimal conditions for specific experimental contexts.

How can researchers assess and improve the sensitivity of meu6 antibody detection methods?

Improving detection sensitivity for the meu6 antibody involves several complementary approaches:

• Signal amplification methods:

  • Implement tyramide signal amplification for immunohistochemistry

  • Use biotin-streptavidin systems to enhance signal

  • Consider polymer-based detection systems for enhanced sensitivity

• Instrumentation optimization:

  • Utilize high-sensitivity imaging systems with cooled CCD cameras

  • Optimize exposure parameters and gain settings

  • Apply image processing techniques to enhance signal-to-noise ratio

• Sample enrichment techniques:

  • Incorporate immunoprecipitation before detection

  • Apply subcellular fractionation to concentrate target proteins

  • Use affinity purification methods to isolate meu6-containing complexes

• Detection reagent considerations:

  • Compare various secondary antibodies from different manufacturers

  • Evaluate different enzyme/substrate combinations for colorimetric detection

  • Test fluorescent secondary antibodies with varied fluorophores

A systematic sensitivity assessment should document the lower limit of detection for each approach, typically expressed as minimum detectable protein quantity.

What are the recommended procedures for validating a new lot of meu6 antibody?

When receiving a new lot of meu6 antibody, thorough validation is essential to maintain experimental consistency:

• Side-by-side comparison:

  • Run parallel experiments with previous and new antibody lots

  • Use identical samples and experimental conditions

  • Quantitatively compare signal intensity and specificity

• Specificity verification:

  • Confirm detection of recombinant meu6 protein

  • Verify absence of signal in knockout/knockdown samples

  • Perform peptide competition assays

• Performance metrics evaluation:

  • Determine optimal working dilution for the new lot

  • Assess detection limit and linear range

  • Evaluate reproducibility across technical replicates

• Documentation and reference sample creation:

  • Generate and store reference samples for future comparisons

  • Document lot-specific performance characteristics

  • Create a standard operating procedure for lot verification

This validation process should be consistently applied to ensure experimental reproducibility and data reliability across studies.

How might the meu6 antibody be adapted for super-resolution microscopy studies?

Adapting the meu6 antibody for super-resolution microscopy requires specialized approaches:

• Conjugation strategies:

  • Direct conjugation to small organic fluorophores (e.g., Alexa Fluor 647)

  • Optimization of dye-to-antibody ratio to prevent self-quenching

  • Purification of conjugated antibody to remove free dye

• Labeling protocol optimization:

  • Minimize background through stringent blocking and washing

  • Reduce fixation-induced autofluorescence

  • Implement specialized mounting media to enhance photostability

• Validation methods:

  • Confirm specificity in super-resolution context

  • Verify labeling density is appropriate for the chosen technique

  • Perform dual-labeling with known markers to confirm localization

• Technical considerations for specific methods:

  • For STORM: Buffer optimization for photoswitching behavior

  • For STED: Selection of fluorophores with appropriate depletion characteristics

  • For SIM: Ensuring sufficient signal-to-noise ratio for pattern recognition

These adaptations can enable nanoscale visualization of meu6 localization and interactions within cellular structures.

What bioinformatic approaches assist in interpreting meu6 antibody experimental data?

Bioinformatic analyses can significantly enhance the interpretation of meu6 antibody experimental results:

• Sequence-based analyses:

  • Homology modeling of protein structure

  • Identification of conserved domains and motifs

  • Prediction of post-translational modification sites

• Network analysis approaches:

  • Integration of co-immunoprecipitation data with existing protein interaction networks

  • Pathway enrichment analysis of interacting partners

  • Functional clustering of associated proteins

• Expression correlation analyses:

  • Integration with transcriptomic data to identify co-regulated genes

  • Correlation analysis with cell cycle markers

  • Temporal expression pattern comparison across conditions

• Comparative genomics:

  • Analysis of meu6 orthologs across yeast species

  • Evolutionary conservation of interaction interfaces

  • Functional divergence assessment in related proteins

These computational approaches provide context for experimental findings and generate testable hypotheses about meu6 function.

How can researchers effectively combine meu6 antibody with CRISPR-based approaches in S. pombe studies?

Integrating meu6 antibody detection with CRISPR technologies offers powerful research opportunities:

• Epitope tagging strategies:

  • CRISPR-mediated insertion of small epitope tags (FLAG, HA, V5)

  • Validation of tag impact on protein function

  • Comparative analysis between endogenous detection and tag-based approaches

• Functional genomics integration:

  • Detection of meu6 protein levels following CRISPR-mediated gene regulation

  • Analysis of protein interactions in CRISPR-generated mutants

  • Correlation of phenotypic outcomes with protein expression levels

• Live-cell imaging approaches:

  • CRISPR knock-in of fluorescent tags combined with antibody validation

  • Development of nanobody derivatives from the antibody for live applications

  • Calibration of fluorescent intensity with absolute protein quantification

• Multiplexed analysis systems:

  • Combined detection of multiple CRISPR-modified proteins

  • Assessment of compensatory mechanisms following gene editing

  • Systematic analysis of genetic interaction networks

This integrated approach leverages the specificity of antibody detection with the precision of CRISPR-based genetic manipulation to advance understanding of meu6 biology.